Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Fortress Biotech Announces $8 Million Registered Direct Offering and Concurrent Private Placements
Sep 20, 2024•over 1 year ago
Contract Type
partnership
New YorkBiotechnologyPharmaceuticalBiopharmaDescription
Fortress Biotech, Inc. announced that it entered into securities purchase agreements with healthcare focused institutional investors for a registered direct offering and a concurrent private placement. The company also had its Chairman, CEO, and President purchase shares and warrants in a separate concurrent private placement. The expected gross proceeds from the offerings are approximately $8 million.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months